Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Qiagen N.V.
(NY:
QGEN
)
45.68
UNCHANGED
Streaming Delayed Price
Updated: 1:35 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Qiagen N.V.
< Previous
1
2
3
4
5
6
Next >
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
August 15, 2022
From
QIAGEN N.V.
Via
Business Wire
Qiagen Posts Robust Q2 Non-COVID Sales Growth, Lifts Annual Guidance
July 27, 2022
Qiagen N.V. (NYSE: QGEN) clocked Q2 FY22 revenues of $516 million, down 9% Y/Y, well above the consensus of $488.73 million.
Via
Benzinga
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
July 27, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook
July 26, 2022
From
QIAGEN N.V.
Via
Business Wire
Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance
May 06, 2022
Via
Benzinga
Qiagen Posts Upbeat Q1 Earnings, Raises FY22 Outlook
April 27, 2022
Via
Benzinga
QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases
July 19, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast
July 07, 2022
From
QIAGEN N.V.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 21, 2022
Good morning, investor! We're back with a breakdown of the biggest pre-market stock movers for Tuesday to get the day started!
Via
InvestorPlace
U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases – Including COVID-19 Outbreaks
June 01, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s Eco-Friendlier Products Earn Prestigious ACT Label
May 19, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
May 16, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Proposes Expansion of Supervisory Board
May 11, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System
May 05, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook
April 26, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to release results for Q1 2022 and hold Webcast
April 20, 2022
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
March 24, 2022
From
QIAGEN N.V.
Via
Business Wire
Earnings Scheduled For April 27, 2022
April 27, 2022
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.
Via
Benzinga
QIAGEN Announces 20-F Annual Report Filing for 2021 Results
March 14, 2022
From
QIAGEN N.V.
Via
Business Wire
Death Cross Looms Over Qiagen Investors
February 17, 2022
If history is any guide, there may be trouble ahead for shares of Qiagen (NYSE:QGEN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Qiagen Q4 Earnings Beat Expectations On High Demand For COVID-19 Tests, Issues FY22 Guidance
February 09, 2022
Qiagen N.V. (NYSE: QGEN)
Via
Benzinga
Qiagen: Q4 Earnings Insights
February 08, 2022
Qiagen (NYSE:QGEN) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Qiagen beat estimated earnings by...
Via
Benzinga
QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year sales growth from non-COVID products
February 08, 2022
From
QIAGEN N.V.
Via
Business Wire
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Qiagen's Earnings: A Preview
February 07, 2022
Qiagen (NYSE:QGEN) is set to give its latest quarterly earnings report on Tuesday, 2022-02-08. Here's what investors need to know before the announcement. Analysts estimate that Qiagen will likely...
Via
Benzinga
Earnings Scheduled For February 8, 2022
February 08, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Via
Benzinga
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
February 07, 2022
From
QIAGEN N.V.
Via
Business Wire
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.